Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atogepant 60mg tablets
0407042U0AAABAB
|
Atogepant | Atogepant | Central Nervous System | 1,597 |
|
Aquipta 60mg tablets
0407042U0BBABAB
|
Aquipta | Atogepant | Central Nervous System | 72 |
|
Atogepant 10mg tablets
0407042U0AAAAAA
|
Atogepant | Atogepant | Central Nervous System | 47 |
|
Aquipta 10mg tablets
0407042U0BBAAAA
|
Aquipta | Atogepant | Central Nervous System | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.